Literature DB >> 33923179

Hexosylceramides and Glycerophosphatidylcholine GPC(36:1) Increase in Multi-Organ Dysfunction Syndrome Patients with Pediatric Intensive Care Unit Admission over 8-Day Hospitalization.

Mara Leimanis-Laurens1,2, Emily Wolfrum3, Karen Ferguson1, Jocelyn R Grunwell4, Dominic Sanfilippo1,2, Jeremy W Prokop2,5, Todd A Lydic6, Surender Rajasekaran1,2,7.   

Abstract

Glycero- and sphingo-lipids are important in plasma membrane structure, caloric storage and signaling. An un-targeted <span class="Chemical">lipidomics approach for a cohort of critically ill pediatric intensive care unit (PICU) patients undergoing multi-organ dysfunction syndrome (MODS) was compared to sedation controls. After IRB approval, patients meeting the criteria for MODS were screened, consented (n = 24), and blood samples were collected from the PICU at HDVCH, Michigan; eight patients needed veno-arterial extracorporeal membrane oxygenation (VA ECMO). Sedation controls were presenting for routine sedation (n = 4). Plasma lipid profiles were determined by nano-electrospray (nESI) direct infusion high resolution/accurate mass spectrometry (MS) and tandem mass spectrometry (MS/MS). Biostatistics analysis was performed using R v 3.6.0. Sixty-one patient samples over three time points revealed a ceramide metabolite, hexosylceramide (Hex-Cer) was high across all time points (mean 1.63-3.19%; vs. controls 0.22%). Fourteen species statistically differentiated from sedation controls (p-value ≤ 0.05); sphingomyelin (SM) [SM(d18:1/23:0), SM(d18:1/22:0), SM(d18:1/23:1), SM(d18:1/21:0), SM(d18:1/24:0)]; and glycerophosphotidylcholine (GPC) [GPC(36:01), GPC(18:00), GPC(O:34:02), GPC(18:02), GPC(38:05), GPC(O:34:03), GPC(16:00), GPC(40:05), GPC(O:36:03)]. Hex-Cer has been shown to be involved in viral infection and may be at play during acute illness. GPC(36:01) was elevated in all MODS patients at all time points and is associated with inflammation and brain injury.

Entities:  

Keywords:  critical illness; glycerolipids; glycerophosphatidylcholine; lipidomics; multi-organ dysfunction syndrome; pediatrics; sphingolipids; sphingomyelin

Year:  2021        PMID: 33923179     DOI: 10.3390/jpm11050339

Source DB:  PubMed          Journal:  J Pers Med        ISSN: 2075-4426


  47 in total

Review 1.  The human plasma lipidome.

Authors:  Oswald Quehenberger; Edward A Dennis
Journal:  N Engl J Med       Date:  2011-11-10       Impact factor: 91.245

2.  Plasma lipidome reveals critical illness and recovery from human Ebola virus disease.

Authors:  J E Kyle; K E Burnum-Johnson; J P Wendler; A J Eisfeld; Peter J Halfmann; Tokiko Watanabe; Foday Sahr; R D Smith; Y Kawaoka; K M Waters; T O Metz
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-11       Impact factor: 11.205

Review 3.  Regulation of phosphatidylcholine biosynthesis.

Authors:  C Kent
Journal:  Prog Lipid Res       Date:  1990       Impact factor: 16.195

4.  Predicting basal metabolic rate, new standards and review of previous work.

Authors:  W N Schofield
Journal:  Hum Nutr Clin Nutr       Date:  1985

Review 5.  Emerging roles for lysophosphatidylserine in resolution of inflammation.

Authors:  S Courtney Frasch; Donna L Bratton
Journal:  Prog Lipid Res       Date:  2012-03-29       Impact factor: 16.195

Review 6.  Neutrophil clearance: when the party is over, clean-up begins.

Authors:  Donna L Bratton; Peter M Henson
Journal:  Trends Immunol       Date:  2011-07-23       Impact factor: 16.687

7.  Concurrent profiling of polar metabolites and lipids in human plasma using HILIC-FTMS.

Authors:  Xiaoming Cai; Ruibin Li
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

8.  The Feasibility of Studying Metabolites in PICU Multi-Organ Dysfunction Syndrome Patients over an 8-Day Course Using an Untargeted Approach.

Authors:  Mara Leimanis-Laurens; Danny Gil; Andrew Kampfschulte; Claire Krohn; Elizabeth Prentice; Dominic Sanfilippo; Jeremy W Prokop; Todd A Lydic; Surender Rajasekaran
Journal:  Children (Basel)       Date:  2021-02-18

9.  Identification of pediatric septic shock subclasses based on genome-wide expression profiling.

Authors:  Hector R Wong; Natalie Cvijanovich; Richard Lin; Geoffrey L Allen; Neal J Thomas; Douglas F Willson; Robert J Freishtat; Nick Anas; Keith Meyer; Paul A Checchia; Marie Monaco; Kelli Odom; Thomas P Shanley
Journal:  BMC Med       Date:  2009-07-22       Impact factor: 8.775

10.  Contributions of amino acid, acylcarnitine and sphingolipid profiles to type 2 diabetes risk among South-Asian Surinamese and Dutch adults.

Authors:  Mirthe Muilwijk; Susan M I Goorden; Carlos Celis-Morales; Michel H Hof; Karen Ghauharali-van der Vlugt; Femke S Beers-Stet; Jason M R Gill; Frédéric M Vaz; Irene G M van Valkengoed
Journal:  BMJ Open Diabetes Res Care       Date:  2020-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.